
Verona Pharma: Targeting $10Bn COPD Market With A Late Stage Drug (NASDAQ:VRNA)
Kobus Louw Background Verona Pharma (NASDAQ:VRNA) is a clinical-stage SMID-cap (~1.6Bn market cap) biotech company based in London, United Kingdom. The company specializes in developing innovative therapies for respiratory diseases such as chronic obstructive pulmonary […]